Helios Biotechnology JSC (HOSE:HSL)
7,820.00
+60.00 (0.77%)
At close: Oct 14, 2026
| Market Cap | 301.60B -17.3% |
| Revenue (ttm) | 10.39B -84.2% |
| Net Income | 2.89B +1.1% |
| EPS | 59.74 -27.7% |
| Shares Out | 38.57M |
| PE Ratio | 130.90 |
| Forward PE | n/a |
| Dividend | 918.20 (11.74%) |
| Ex-Dividend Date | n/a |
| Volume | 338,891 |
| Open | 7,800.00 |
| Previous Close | 7,760.00 |
| Day's Range | 7,680.00 - 7,900.00 |
| 52-Week Range | 4,700.00 - 11,200.00 |
| Beta | 0.36 |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Oct 28, 2026 |